Dr. Gillett & James O'Hara discuss the FDA ruling on MDMA. 00:00 Intro 01:10 FDA's decision on MDMA therapy is pending, with possibilities ranging from approval. 06:00 MDMA affects various hormones post-consumption, including serotonin and cortisol, potentially impacting mood and physiology. 09:30 MDMA trials for PTSD 14:55 Concerns over MDMA trials 21:32 FDA critiques MDMA therapy training protocols for therapists to prevent abuse. 24:33 MDMA is considered safer compared to benzodiazepines in certain respects. 27:33 Balancing drug accessibility and safety through regulatory measures is crucial to advancing scientific research and ensuring public health. 29:30 Outro Studies/References: ► https://sci-hub.se/https://pubmed.ncbi.nlm.nih.gov/31734398/ ► https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205851/ ► https://www.nature.com/articles/s41591-023-02565-4 ► https://abcnews.go.com/Health/fda-advisers-recommending-mdma-treatment-ptsd/story?id=110808948 For High-Quality Labs: ► https://gilletthealth.com/order-lab-panels/ For information on the Gillett Health clinic, lab panels, and health coaching: ► https://GillettHealth.com Follow Gillett Health for more content from James and Kyle ► https://instagram.com/gilletthealth ► https://www.tiktok.com/@gilletthealth ► https://twitter.com/gilletthealth ► https://www.facebook.com/gilletthealth Follow Kyle Gillett, MD ► https://instagram.com/kylegillettmd Follow James O’Hara, NP ► https://Instagram.com/jamesoharanp For 10% off Gorilla Mind products including SIGMA: Use code “GH10” ► https://gorillamind.com/ For discounts on high-quality supplements ►https://www.thorne.com/u/GillettHealth #ptsd #fda #podcast Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy